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Abstract
Purpose: Various factors cause geometric uncertainties during prostateradiotherapy, including interfractional and intrafractional patient motions, organmotion, and daily setup errors. This may lead to increased normal tissuecomplications when a high dose to the prostate is administered. More-accuratetreatment delivery is possible with daily imaging and localization of the prostate.This study aims to measure the shift of the prostate by using kilovoltage (kV) conebeam computed tomography (CBCT) after position verification by kV orthogonalportal imaging (OPI). Methods: Position verification in 10 patients with prostatecancer was performed by using OPI followed by CBCT before treatment delivery in25 sessions per patient. In each session, OPI was performed by using an on-boardimaging (OBI) system and pelvic bone-to-pelvic bone matching was performed.After applying the noted shift by using OPI, CBCT was performed by using the OBIsystem and prostate-to-prostate matching was performed. The isocenter shiftsalong all three translational directions in both techniques were combined into athree-dimensional (3-D) iso-displacement vector (IDV). Results: The mean (SD)IDV (in centimeters) calculated during the 250 imaging sessions was 0.931 (0.598,median 0.825) for OPI and 0.515 (336, median 0.43) for CBCT, p-value was lessthan 0.0001 which shows extremely statistical significant difference. Conclusion:Even after bone-to-bone matching by using OPI, a significant shift in prostate wasobserved on CBCT. This study concludes that imaging with CBCT provides a moreaccurate prostate localization than the OPI technique. Hence, CBCT should bechosen as the preferred imaging technique.
Keywords: Cone Beam Computed Tomography; Organ Motion; Orthogonal PortalImaging; Prostate Cancer
1. IntroductionProstate cancer is the second most common type ofcancer and the fifth leading cause of cancer-relateddeath in men worldwide.1 Prostate cancer can bemanaged by using surgery, chemotherapy, radiotherapy,and so on. Among these treatment options, radiotherapyis considered superior in terms of survival rate and sideeffects. Three-dimensional conformal radiotherapy(3-DCRT), intensity-modulated radiotherapy (IMRT),imaging-guided radiotherapy (IGRT), volumetric
modulated arc therapy (VMAT) and intensity modulatedproton therapy (IMPT) are various modern techniquesby which prostate cancer can be treated.2,3 All thesemodern radiotherapy techniques basically focus onlethal-dose delivery to the target volume and minimumdose delivery to the organs at risk (OAR).4In IMRT, propinquity between the prostate and the OARsuch as the bladder and rectum often leads to highly
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inhomogeneous fluence profiles, with steep dosegradients in concave, tumor wrapped around the OAR orin convex structures. In addition, in the case of prostatecancer, many factors cause geometric uncertaintiesduring prostate radiotherapy, including interfractionaland intrafractional patient motions, organ motion, anddaily setup errors.5 This may lead to increasedcomplications in OAR when a high dose to the prostate isadministered. Hence, more-accurate treatment deliveryis possible with proper patient immobilization andaccurate setup verification by using the adequateimaging technique before delivering each fraction.Published studies demonstrate that the tumor controlprobability (TCP) and toxicity of OAR are closelyassociated with proper treatment execution.Radiotherapy with better accuracy is sufficient toimprove the TCP and decrease treatment-relatedmorbidity.6 Bentel et al.7 demonstrated the effectivenessof immobilization and emphasized the requirements forimproving immobilizing techniques. Mounting theon-board imaging (OBI) system on the gantry of amedical electron linear accelerator (Clinac) is efficient toverify patient setup accuracy and positionreproducibility.8,9 Earlier study done on comparisonbetween kilovoltage (kV) orthogonal portal imaging(OPI) and kV-cone beam computed tomography (CBCT)imaging for various sites viz. brain, head-and-neck andpelvis shows that OPI is enough in the case of brain andhead-and-neck cases as the target volume doesn’t movesignificantly with respect to bones in such sites, howeverthe study recommended that CBCT should be preferredin the case of sites with movable targets e.g. prostatecancer.9 In general, daily imaging is advised in the caseof prostate cancer and is considered as the standardpractice.10,11 However, in many centers, daily imaging isnot performed even in the case of moving targets such asprostate cancers owing to the unavailability of imagingtechniques or high patient workload, and many centersimplement a protocol for daily portal imaging.The OBI system consists of two kinds of imagingtechniques, namely kV-OPI and kV-CBCT. In this study,the position verification with the OPI technique wascross-verified by using the CBCT technique.
2. Methods and MaterialsA prospective study was conducted from July 2014 toJanuary 2015 with 10 patients with prostate cancer whowere scheduled for imaging IGRT at a dose of 50 Gy in25 fractions (#) at the rate of 2Gy/# in the firsttreatment phase. Although a total dose of 78 Gy/38#was planned and delivered in the first, second, and thirdphases of the treatment plan, this study was conductedduring the first treatment phase only. Patients withhistologically confirmed early-stage prostate cancer,except patients with nodal metastasis, were selected forthe study. The age of the patients ranged from 50 to 80
years. In this study, the accuracy of the positionverification with the OPI technique was cross-verified byusing the CBCT technique. With the OPI technique, 250imaging sessions (10 patients × 25#) were performed.Same person was involved in the imaging procedures forall the patients and imaging sessions to avoid the personto person differences.Full bladder protocol was followed by most of thepatients and each patient was suggested for urine passand then to drink 200 ml of water 30 minutes beforetaking on the couch in each session. However, fewpatients did not follow this protocol due to their criticalclinical problems.For all of the patients, six clamp thermoplastic sheets(Orfit) for the immobilization of the pelvic region weremolded in the molding room. Then, computedtomography (CT) was performed by using the SiemensSOMATOM Definition AS scanner (Siemens MedicalSystems, Germany). The CT images of 3-mm-thick sliceswere acquired and transferred to the treatmentplanning system (TPS) Eclipse version 8.9 (VarianMedical Systems, Palo Alto, CA). Gross tumor volume(GTV), clinical target volume (CTV), planning targetvolume (PTV), and OAR were delineated on the CTimages, following the guidelines of the InternationalCommission on Radiation Units and Measurementsreport No. 83 (ICRU 83).12 PTV margin of 0.5 cm aroundthe CTV was given in all the cases. IGRT plans werecreated with a 6-MV photon beam, and Varian leafmotion calculator version 8.9.08 was utilized to calculateleaf motion for dynamic dose delivery. A dose volumeoptimizer (DVO) was used for planning optimization.Anisotropic analytical algorithm (AAA) was used tocalculate doses with a grid size of 0.25 cc. After approval,the plans were scheduled for 25 fractions with dailyimaging with the OPI and CBCT techniques.The patients were positioned and immobilized on thecouch of the Varian Clinac DMX (Varian Medical Systems,Palo Alto, CA) by using the thermoplastic sheet moldedfor them. Then, OPI and CBCT were performed with theOBI system (Varian Medical Systems, Palo Alto, CA)consisting of a 125-kVp x-ray tube isocentricallymounted to the gantry of the Clinac. It was operatedfrom the treatment console. Anatomy-matchingsoftware (Varian Portal Vision 7.5) was used to studythe patient setup deviations and to determine the spatialcoordinates in the images. The ARIA networking system(Varian Medical Systems Inc.) was used to upload thereference images from the TPS.Before each treatment session, OPI was performed withan imager vertical distance of 50 cm, where two portalimages were taken at gantry angles of 0° and 90°,respectively. The portal images were superimposed onreference digitally reconstructed radiograph (DRR)images, and two pelvic bones were matched by using the
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spyglass technique as shown in Figure 1 (a), in which amovable inner window separated the reference DRR onthe inside from the OPI image on the outside. Theencompass is appraised by examining the continuity of
the bones across the edges of the inner window.13 Theisocenter shifts along three translational directions,namely the lateral, longitudinal, and vertical directions,were noted and applied to the Clinac couch.
Figure 1: Registration window of the on-board imaging system (OBI) for (a) orthogonal portal imaging (OPI) and (b) conebeam computed tomography (CBCT).As the prostate is a soft tissue organ whose position mayvary according to the position of the bones, tocross-verify the matching performed by using the OPItechnique, CBCT was performed at an imager verticaldistance of 50 cm and by using a full-bowtie filter. CBCTwas performed by rotating the gantry in thecounterclockwise direction from 179° to 180° (360°rotation). The CBCT images were fused with thereference CT images, and two prostates were matched asshown in Figure 1 (b), with the help of transversal,frontal, and sagittal views by using the above-mentionedspyglass method. The isocenter shifts along the threetranslational directions were noted and applied to theClinac couch.In the two above-mentioned techniques, rotational shiftwas not considered. However, it was very small (<1°) infew imaging sessions. The shifts in all the threetranslational directions in each of the 250 sessions forboth techniques were noted and analyzed. The meanvalues and standard deviation (SD) were calculated. Theisocenter shifts along all the three translationaldirections in both techniques were combined in to a 3-Disodisplacement vector (IDV), which is defined as E =(vert2 + long2 + lat2)1/2.9 Paired t-test was applied tocalculate the p-value for the statistical analysis of thedifference between IDV calculated in OPI and CBCTtechniques.
3. ResultsPatient position verification before each of the 250treatment sessions (10 patients × 25#) was performedby using OPI. The mean (SD) [median] shifts (incentimeters) were 0.230 (0.261) [0.2], 0.792 (0.628)[0.7], and 0.212 (0.190) [0.1] in the vertical, longitudinal,and lateral directions, respectively. To cross-verify theposition, CBCT was performed, and the mean (SD)[median] shifts (in centimeters) were 0.125 (0.117)[0.1], 0.425 (0.331) [0.3], and 0.199 (0.139) [0.2] in the
vertical, longitudinal, and lateral directions, respectively.The shifts in all the three translational directions in the250 imaging sessions that were measured by using OPIand CBCT are depicted in Figures 2 and 3, respectively.The obtained setup errors in this study are systematicand random errors for the currently applied treatmenttechniques, using basic immobilization devices.
Figure 2: The shifts in all the three translational directions,namely the vertical (Vrt), longitudinal (Long), and lateral(Lat) directions, from the 250 imaging sessions that weremeasured by using orthogonal portal imaging.
Figure 3: The shifts in all the three translational directions,namely the vertical (Vrt), longitudinal (Long), and lateral(Lat) directions, from the 250 imaging sessions that weremeasured by using cone beam computed tomography.
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The mean (SD) [median] IDV (in centimeters) calculatedduring the 250 imaging sessions was 0.931 (0.598)[0.825] for OPI and 0.515 (336) [0.43] for CBCT,respectively. The calculated p-value was less than0.0001 which shows the extremely statistical significantdifference between the IDV calculated in both thetechniques.
Table 1 shows the mean IDV for each of the 10 patientsthat was calculated by using the shifts in all the threetranslational directions measured by using OPI andCBCT.
Table 1: Measured shifts, calculated isodisplacement vector (IDV), standard deviation (SD), and median values for 10patients with prostate cancer.Patientno. No. ofimagingsessions OPI CBCTMean vrt.Shift in cm(SD) Meanlong. Shiftin cm(SD) Mean lat.Shift incm (SD) MeanIDV incm (SD) Mean vrt.Shift incm (SD) Meanlong. Shiftin cm(SD) Mean lat.Shift incm (SD) MeanIDV incm (SD)1 25 0.212(0.203) 0.700(0.496) 0.224(0.136) 0.832(0.441) 0.128(0.124) 0.252(0.139) 0.160(0.112) 0.355(0.161)2 25 0.148(0.126) 0.956(0.804) 0.320(0.227) 1.069(0.778) 0.112(0.078) 0.552(0.245) 0.256(0.112) 0.632(0.249)3 25 0.192(0.204) 0.732(0.628) 0.18(0.189) 0.844(0.601) 0.068(0.114) 0.440(0.359) 0.196(0.137) 0.514(0.364)4 25 0.116(0.099) 1.004(0.603) 0.180(0.208) 1.061(0.585) 0.060(0.071) 0.332(0.177) 0.172(0.098) 0.397(0.178)5 25 0.096(0.124) 1.012(0.746) 0.288(0.244) 1.110(0.715) 0.132(0.090) 0.568(0.305) 0.204(0.117) 0.632(0.311)6 25 0.136(0.132) 0.884(0.593) 0.148(0.145) 0.942(0.567) 0.084(0.089) 0.264(0.170) 0.140(0.108) 0.330(0.190)7 25 0.576(0.514) 0.668(0.498) 0.232(0.168) 1.046(0.517) 0.196(0.089) 0.796(0.391) 0.288(0.120) 0.881(0.392)8 25 0.272(0.184) 0.916(0.703) 0.200(0.216) 1.033(0.676) 0.144(0.133) 0.5640.467) 0.308(0.222) 0.683(0.500)9 25 0.324(0.217) 0.472(0.374) 0.180(0.168) 0.658(0.373) 0.104(0.079) 0.280(0.141) 0.180(0.096) 0.364(0.154)10 25 0.228(0.179) 0.580(0.569) 0.172(0.121) 0.715(0.523) 0.220(0.173) 0.200(0.198) 0.092(0.086) 0.365(0.198)Mean of 250imaging sessions 0.230 0.792 0.212 0.931 0.125 0.425 0.199 0.515SD of 250 imagingsessions 0.261 0.628 0.190 0.598 0.117 0.331 0.139 0.336Median of 250imaging sessions 0.200 0.700 0.100 0.825 0.100 0.300 0.200 0.430
4. DiscussionThis was a prospective study conducted to investigatethe efficacy of OPI as the imaging technique duringprostate cancer radiotherapy by cross-verification byusing the CBCT technique. The scope of OPI is limited tothe set-up corrections utilizing bony landmarks. It is awell-known fact that for sites that have limited movingstructures such as the brain and the head-and-neckregion, utilizing bony information is adequate for setuperror correction for advanced radiotherapy treatments.OBI was introduced because of its potential to visualize3-D soft tissue anatomy. CBCT image acquisition is basedon a large number of projections and thus is likely toprovide superior quantitative spatial information overthat provided by a planar kV image acquisition usingOPI.The imaging results obtained by using OPI concurredwith the results of the published studies on daily
imaging for prostate cancer radiotherapy.14,15 The setuperrors in this technique include the systematic andrandom errors as the basic immobilization devices; thatis, only a thermoplastic sheet with a flat pelvic base plateis used. Although the shifts measured by using CBCT aresmaller than those in OPI, the large shifts measured byusing OPI had been nullified. Thus, the results obtainedby using CBCT cannot be compared with the resultsobtained by using OPI in this study or the results ofother studies already published on imaging by using theOPI or CBCT technique for prostate cancer. However, theshift measured by using CBCT even after OPI is due tothe interfractional and intrafractional motions of theprostate according to the position of the pelvic bones,5,16and this daily shift cannot be corrected by using bonylandmarks based on OPI.Although the doses may be slightly higher in the case ofCBCT, the purpose of CBCT is image guidance, which has
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its benefits. However, Walter et al.17 indicated thatonetime CBCT of the pelvic region delivers 17.2 mGy tothe rectum, ≤28 mGy to the surface, and 10.2 mGy to thecenter of the body, and the peripheral computedtomography dose index (CTDI) is 23.6 mGy. However, ifit is calculated for 38#, then the dose will remain at65.36 cGy to the rectum, ≤106.4 cGy to the surface, and38.76 cGy to the center, and the CTDI will be 89.68 cGy.These values are in 38# and hence are negligible ifcompared with the pelvic dose tolerance values for OAR.Since CBCT as a position verification tool is more timeconsuming, daily imaging with the OPI technique andperforming CBCT once or twice a week can improve theprecision and effectiveness of prostate cancertreatment.18 Table 1 shows that the mean IDV with CBCTwas below 0.5 cm for five patients but >0.5 cm foranother five patients, showing that the prostate shiftaccording to the position of the pelvic bones variesbetween patients. In addition, Figure 2 clearly indicatesthat the prostate shift in all three directions, namely thevertical, longitudinal, and lateral directions, is low forimaging sessions 1 to 25 (i.e., patient No. 1), 125 to 150(i.e., patient No. 6), and 200 to 250 (i.e., patient Nos. 9and 10) but high (specially longitudinal shift) forimaging sessions 150 to 200 (i.e., patient Nos. 7 and 8). Amajor factor along with the other reasons for such kindof shift is the rectum and bladder filling during theradiotherapy.19 Moiseenko et al.20 concluded in theirstudy that bladder volume does not affect prostate shiftand PTV underdosing / overdosing but that dailyvariation in bladder volume causes the undesirable dosedelivery to it. Thus, in general, if the volumes of therectum and bladder are maintained throughout theradiotherapy procedure while performing CT for thepatients before planning and positioning them on theClinac couch for each treatment session, then theprostate shift and doses to the OAR can be managed asper the planning performed on TPS. However, manypatients cannot cooperate due to their own clinicalproblems; hence, daily CBCT becomes very important insuch cases.21
5. ConclusionImaging with CBCT provides more-accurate prostatelocalization than the OPI technique in prostate cancercases. In this study, even after bone-to-bone matching byOPI, a significant shift in the prostate was observedwhen position was cross-verified by CBCT.CBCT shouldbe chosen as the preferred imaging technique. By usingthis imaging technique, tighter margins at theprostate-rectal interface can be used, thus preventing anundesirably high dose to the rectum and bladder.
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